Marketing > CASE STUDY > Metabical Case Study University of Maryland, University College MRKT 310 (All)

Metabical Case Study University of Maryland, University College MRKT 310

Document Content and Description Below

Metabical: Pricing, Packaging, and Demand Forecasting… 1. How does Metabical compare to current weight loss options? When you look at the current weight loss options, one would see that upon appro... val, Metabical would be the only prescription drug for weight loss approved by the FDA. Compared to other drugs that offer weight loss, Metabical has fewer side effects and since Metabical combines an appetite suppressant and fat-blocking effects in a multi-layer pill, it creates a market that targets obese people and addresses their weight loss needs. Metabical also works in low dosage so its side effects are very minimal. It’s very well known that prescription drugs often come with side effects, however Metabical does an excellent job minimizing that. It has almost no side effect and that makes for a great selling point when compared to the other options. If you look at the side effects listed for some of Metabical competitions, long-term side effects include liver failure and gallbladder disease. These side effects can prove to be fatal. Compared to the other weight loss option drugs offered, Metabical is not only safe but it is effective. 2. What are the pros and cons of the forecasting methods presented by Printup? If you had to estimate demand for this product, how would you go about it? What would your demand (unit) forecast look like for the first five years? Pros: Considers the whole population of the United States, it targets a populations that is ready to begin using the product upon approval and use which makes data more precise. Cons: Not all the data from the survey is being used, this makes it harder to estimate the amount of people actually willing to trust and use the drug, since number for drug use is coming from a survey sample, data can be inaccurate, thus narrowing down the market. I would estimate the demand for this product to be either as successful or more successful than its competitors, such as Alli or CSP. Demand forecast | | U.S. Grown-up Population | BMI 25-35 | | Comfortable Taking Pills | | Market Share | | Year 1 | 209,000,000 | 3 [Show More]

Last updated: 2 years ago

Preview 1 out of 5 pages

Buy Now

Instant download

We Accept: